Fresenius, DE0005785604

Fresenius stock heads into the open after a 1.86 percent fall

Published on 09/23/2026 at 08:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, Fresenius stock fell 1.86 percent on Xetra and underperformed the DAX session. The S&P 500 gained 1.49 percent to 7,764.70 points on September 22, 2026.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht
Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock closed 1.86 percent lower on Xetra on September 21, 2026. The decline made Fresenius the weakest DAX 40 constituent in that session, according to AD HOC NEWS.

September 21, 2026 in numbers

Fresenius SE and Co. KGaA (ISIN DE0005785604, Xetra: FRE) recorded a 1.86 percent loss on September 21, 2026. The available session report identifies important simple moving average support levels as the immediate chart reference, but does not attach a new fundamental announcement to the move.

The documented comparison was unfavorable: Fresenius fell 1.86 percent and ranked as the DAX 40 session loser. A separate market report said the S&P 500 gained 1.49 percent to close at 7,764.70 points on September 22, 2026, while the Nasdaq 100 rose 2.83 percent to 30,482.35 points.

September 23, 2026 trading context

Fresenius also had a USD 21.82 OTC market indication at 3:40 p.m. ET on September 22, 2026, but that value was explicitly described as an intraday quote rather than a regular-session close. The US market backdrop included a 1.49 percent S&P 500 gain on September 22, 2026, as reported by AD HOC NEWS.

Disclaimer...

en | DE0005785604 | FRESENIUS | boerse | 70164064 | bgmi